WuXi AppTec Co., Ltd.

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 7, 2024), WuXi AppTec Co., Ltd. reported 2 stock positions worth $29.4 million. Its top holding was Lyell Immunopharma (LYEL) at 62.1% of the portfolio, followed by Adagene Inc.-ADR (ADAG, 37.9%). Compared with Q4 2023, it sold out of 3 and reduced 1. The biggest sale was an exit from New Ambrx Biopharma (AMAM).

Most Recent 13F
Q3 2024
Location
Shanghai, F4
CIK
0001832424
Portfolio Value
$29.4M (Q1 2024)
SEC Filing
0001104659-24-058027 ↗ filed May 7, 2024

Holdings Value

0$10.0M$20.0M$30.0M Q1 2024: $29.4M $29.4M Q1 2024 Q2 2024: $23.3M Q2 2024 Q3 2024: $19.0M Q3 2024

Holdings 2 stocks · $29.4M
LYEL Lyell Immunopharma Inc. 62.06% 8,180,678 $18.2M No change
ADAG Adagene Inc.-ADR 37.94% 3,982,902 $11.2M Reduce -5.8%

Portfolio Sells Q4 2023 → Q1 2024
AMAM New Ambrx Biopharma Inc. Sold out 0.00% −36.92
PPBT Purple Biotech Ltd. Sold out 0.00% −0.39
CSTL Castle Biosciences Inc. Sold out 0.00% −0.37
ADAG Adagene Inc.-ADR Reduce -5.8% 37.94% +16.78

Portfolio Buys Q4 2023 → Q1 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q3 2024 2$19.0MLYEL, ADAG
Q2 2024 2$23.3MADAG, LYEL
Q1 2024 2$29.4MLYEL, ADAG